Clinical Pharmacokinetics of Tacrolimus
- 1 December 1995
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 29 (6) , 404-430
- https://doi.org/10.2165/00003088-199529060-00003
Abstract
Tacrolimus, a novel macrocyclic lactone with potent immunosuppressive properties, is currently available as an intravenous formulation and as a capsule for oral use, although other formulations are...Keywords
This publication has 99 references indexed in Scilit:
- Stability of FK 506 in Whole Blood SamplesTherapeutic Drug Monitoring, 1995
- Interaction between tacrolimus and erythromycinThe Lancet, 1994
- Pharmacokinetics of FK506 After Intravenous and Oral Administration in Patients Awaiting Renal TransplantationThe Journal of Clinical Pharmacology, 1994
- Comparison of Different Assays for the Quantitation of FK 506 Levels in Blood or PlasmaTherapeutic Drug Monitoring, 1994
- Isolation and identification of a FK-506 C36–C37 dihydrodiol from erythromycin-induced rabbit liver microsomesJournal of Pharmaceutical and Biomedical Analysis, 1994
- Distribution and Protein Binding of FK506, a Potent Immunosuppressive Macrolide Lactone, in Human Blood and Its Uptake by ErythrocytesJournal of Pharmacy and Pharmacology, 1994
- Validation and Quality Assurance Program for Monitoring Tacrolimus (FK 506) Concentrations in Plasma and Whole BloodTherapeutic Drug Monitoring, 1993
- TacrolimusDrugs, 1993
- Liver, Kidney, and Thoracic Organ Transplantation Under FK 506Annals of Surgery, 1990
- Cyclosporine Concentration Determinations for Monitoring and Pharmacokinetic StudiesThe Journal of Clinical Pharmacology, 1986